Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soroush-Mana Pharmed is a specialized biotechnology company based in Iran that focuses on the development and production of high-value recombinant proteins. The company is a leader in the domestic production of coagulation factors, notably offering recombinant Factor VIII (Safacto) and Factor IX (Smana-IX) for the treatment of Hemophilia A and B. As a designated knowledge-based enterprise, it utilizes advanced bioprocessing technologies to manufacture biosimilars that meet international quality standards. Its operations are centered in the Pardis Technology Park, where it maintains state-of-the-art GMP-compliant manufacturing facilities to serve the Iranian and regional healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soroush-Mana Pharmed.